Clinic and Education

Xuanwu Hospital Capital Medical University —— Cerebral Revascularization Center

Supported by the Ministry of Science and Technology of China under the 10th Five-Year Plan
Supported by the Ministry of Science and Technology of China under the "Second Five-Year Plan".
Developed the "National Health Planning Commission Carotid Endarterectomy Procedure Guidelines".
Head of the Carotid Artery Stenosis Lecture Tour of the Brain Defence Committee of the National Health Planning Commission.
RECAS Trial Published
IAT-TOP, CMOSS-2, and VISTA initiated; illustrated carotid endarterectomy published; CMOSS Trial published in JAMA
Prof Ling Feng formed a team
Supported by Beijing Municipal Major Science and Technology Tackling Programme
First batch of "National Training Centre for Carotid Endarterectomy" and "National Training Centre for Carotid Stenting" under the National Health and Planning Commission (NHPC).
Awarded the "National Major Research and Development Programme" by the Ministry of Science and Technology.
Establishment of the "Cerebral Revascularization Center" combining neurology and neurosurgery
CASSISS Trial published in JAMA, CRITICAS Trial published in SVN
Section motto

As though on the brink of an abyss, as though treading on thin ice

Do your best, be all you can be

Carotid Endarterectomy (CEA): The inception of CEAe dates back to 1951. Since 1990, it has been widely adopted as the prevailing method for treating carotid artery stenosis in Europe and the U.S. The benefits of CEA stem from the well-developed nature of the technique and its enduring, consistent effectiveness. Our team continuously monitors cerebral blood flow during CEA surgery and utilizes meticulous manual techniques for precise treatment.

The National Team for Stroke Prevention and Treatment

The Two Guns for Cerebral Gastric Tube Reconstruction

         Our team holds the position of chairman in the Cerebral Hypotension Surgery Committee of the Brain Defense Committee of the National Healthcare Commission, as well as vice chairman in the Cerebral Hypotension Intervention Committee. Our team, functioning as a "national team," integrates the strengths of both manual and interventional therapy. Furthermore, all of our doctors possess dual expertise in both domains, making them highly proficient in both areas. We take great pride in being recognized as one of the premier teams on a global scale.

Carotid Artery Disease

Intracranial Artery Disease

Carotid artery and intracranial artery occlusion

Intracranial artery backbone plasty: This technique was developed in the 1990s. Due to the infrequency of the disease, it has received limited attention in Europe and the United States. However, rapid development is occurring in East Asia. We have spearheaded the most extensive clinical investigation on intracranial artery stenting globally, and our center boasts the most exceptional outcomes and safety records worldwide.

Intracranial and extracranial arterial bypass surgery: With its inception in 1967, this procedure enhances cerebral blood flow by surgically connecting the blood vessels of the scalp to those of the brain. The CMOSS study was conducted by our team to investigate the efficacy of intracranial and extracranial arterial bypass grafting through a randomized controlled trial. We are the leading center in China for intracranial and extracranial bypass surgery, renowned for our exceptional outcomes and commitment to safety.

Carotid Artery Support Plasty (CAS): It was developed during the 1990s. Since 2010, technological advancements have made it a comparable alternative to CEA. The benefits of this approach include reduced invasiveness and enhanced patient comfort. The defining features of our team are the implementation of "standardized clinical pathways" and the unwavering commitment to achieving the utmost safety in every outcome.

Pharmacological treatment: The treatment primarily comprises standardized anti-granulocyte medication and statin therapy, widely acknowledged globally. Our team conducted a randomized controlled study to compare the effectiveness of pharmacological therapy and intracranial arterial stenting. We will formulate an individualized treatment strategy derived from meticulous assessment.

Hybrid recanalization surgery: This is a developing surgical technique that has gained prominence in recent years. The procedure begins with using carotid endarterectomy to open the blocked section of the blood vessel. Then, interventional therapy is employed to reach the distal part of the artery and reopen the blocked artery using stenting. With its exceptional expertise, the team stands out as one of the most advanced in the world. It consistently treats the most significant number of patients annually, delivering superior results and ensuring utmost safety during the procedure.

Stenosis and occlusion of carotid arteries

Between 2001 and 2023, our team successfully conducted 5,707 carotid endarterectomies and 3,665 carotid stenting procedures. We have performed the most significant surgical procedures and stentings in China in a single medical center. Additionally, we have consistently achieved a complication rate of less than 1.4%.

Carotid endarterectomy: All patients receive meticulous and precise testing of cerebral blood flow during the procedure, and microsurgical treatment is consistently maintained. Typically, patients are released from the hospital within four days following their surgical procedure.

Carotid stenting and cannuloplasty: Stent implantation is a brief procedure, typically

lasting less than an hour. Typically, patients are discharged from the hospital within a span of 3 days following the procedure.

Hybrid recanalization surgery of carotid artery occlusion : This approach integrates surgical procedures with interventional therapy to treat patients with intricate carotid occlusions. Since 2007, our team has been at the forefront of introducing and developing these procedures in China. By the conclusion of 2023, a total of 509 procedures have been conducted, achieving an occlusion recanalization rate of 91.7% and a complication rate below 3%. Simultaneously, we have enhanced the initial laborious steps of the procedure and devised novel methods for executing it. Our center is highly populated, technologically sophisticated, and secure, making it one of the most advanced centers globally.

Stenosis and occlusion of intracranial arteries

Between 2002 and 2023, our team successfully performed 3864 cases of intracranial artery stent trephination, with a low complication rate of only 4.18%.

Intracranial arterial stenting: All patients at our centre are accurately evaluated by high-resolution MRI and the best international intracranial stents are used during the procedure. Patients are usually discharged within 3 days after surgery. In the field of intracranial arterial stenosis, our team has received strong support from the Ministry of Science and Technology of the People's Republic of China (MOST) under the Second Five-Year Plan and the Third Five-Year Plan, and the technology has reached an international leading position.

Stenosis or occlusion of vertebral arteries

Between 2002 and 2023, our team conducted 3362 instances of vertebral artery stenting angioplasty, achieving a meager complication rate of only 0.51%.

Vertebral artery stenting angioplasty:It is a short and preferred procedure for treating vertebral artery stenosis. Typically, patients can be released from the hospital within 48 hours following the procedure.

Hybrid recanalization surgery of vertebral arteriy occlusion: Patients not eligible for stent angioplasty can only be treated through "Hybrid" surgical intervention. Our team has pioneered the development and implementation of compound surgery for recanalizing occluded vertebral arteries, as well as using stenting to address restenosis in these arteries.

These surgical techniques were the first of their kind to be invented and performed at the international level.

Chronic intracranial arterial occlusion

Between 2002 and 2023, our team successfully concluded 347 cases, achieving a complication rate of merely 3.4 percent. Intracranial and extracranial arterial bypass surgery is highly challenging, necessitating 8-12 sutures in a fistula with a diameter of 1.5 mm, which demands a high degree of surgical proficiency. The team has received training from Professor Yasargil, a renowned neurosurgeon and the creator of the procedure. The physicians in our team have completed extensive and demanding training. Dr. Ma Yan has led the team in establishing the Yasargil Microneurosurgery Training Centre, where hundreds of proficient bypass surgeons have been trained nationwide.

Medical Work Team 1
Medical Work Team 3
Medical Work Team 2
Chief Ward Officer
Deputy attending-in-charge
Deputy attending-in-charge
Chief Ward Officer
Deputy doctor-in-charge
Deputy attending-in-charge
Dr. Fengshui Zhu
Dr. Fei Chen
Dr. Liqun Jiao
Dr. Jian Chen
Dr. Peng Gao
Dr. Yan Ma
Medical Work Team 4
Dr. Yanfei Chen
Dr. Bin Yang
Dr. Yabing Wang

         The CRC team, which established the nation's first neurointerventional training center in 1994 and has trained over 1,500 neurointerventionalists in China over the previous 30 years, is heavily invested in teaching. These individuals have participated in and advanced the field of neurointervention in China. The CRC team actively enlists neurosurgeons and neurologists nationwide to visit the site and acquire knowledge on interventional and surgical techniques. Neurosurgery and Neurology specialists nationwide gather to acquire knowledge in interventional and surgical techniques. Annually, in my capacity as the chairman of the Neurointerventional Committee of the Continuing Education Centre of the National Healthcare Commission, we commence a nationwide training program. The CRC team has introduced a 12-month training program in ischemic cerebrovascular disease and a 4-month training program in carotid endarterectomy. These programs aim to provide doctors with advanced training opportunities by utilizing a comprehensive database management and imaging platform and a wide range of clinical groups. The CRC team places significant emphasis on fostering the scientific research capabilities of physicians. The Neurological Intervention Training Institute of Capital Medical University has been established, and a cutting-edge training program in clinical research has been initiated. Utilizing our exceptional clinical research capabilities, the CRC team offers tailored training programs to doctors, enabling them to become proficient "clinical research scientists" and providing advanced training to esteemed neurologists and neuroscientists in China. Thus far, we have registered 46 cohorts of students, amounting to over 1,000 individuals.


+8615633140085(Site Manager:Dr.Shengyan Cui)



Xuanwu Hospital, Capital Medical University

45 Chang Chun Street

Xicheng District, Beijing, China

Email:  (Team Manager Dr.Wang Tao)


Cerebral Recanalization Center CHINA-INI(@sss405084186525)